Genetic Analysis of Type 1 Diabetes: Embryonic Stem Cells as New Tools to Unlock Biological Mechanisms in Type 1 Diabetes

Nick Holmes, Anne Cooke

Read More

Pathogenic Mechanisms in Type 1 Diabetes: The Islet is Both Target and Driver of Disease

Kate L. Graham, Stuart I. Mannering, Yuxing Zhao, Jonathan Chee, Balasubramanian Krishnamurthy, Helen E. Thomas ,Robyn M. Sutherland, Andrew M. Lew ,Thomas W.H. Kay

Read More

Comparative Genetics: Synergizing Human and NOD Mouse Studies for Identifying Genetic Causation of Type 1 Diabetes

John P. Driver ,Yi-Guang Chen ,Clayton E. Mathews

Read More

Protein Tyrosine Phosphatases and Type 1 Diabetes: Genetic and Functional Implications of PTPN2 and PTPN22

Karen Cerosaletti and Jane H. Buckner

Read More

From Markers to Molecular Mechanisms: Type 1 Diabetes in the Post-GWAS Era

Alan G. Baxter and Margaret A. Jordan

Read More

Novel Biomarkers in Type 1 Diabetes

Yulan Jin, Jin-Xiong She

Read More

Metabolomics in the Studies of Islet Autoimmunity and Type 1 Diabetes

Matej Oresic

Read More

Gut Microbiota and Type 1 Diabetes

Outi Vaarala

Read More

Virus Infections as Potential Targets of Preventive Treatments for Type 1 Diabetes

Noora Nurminen , Sami Oikarinen, Heikki Hyöty

Read More

Helminth Infection and Type 1 Diabetes

Paola Zaccone and Samuel W. Hall

Read More

Type 1 Diabetes Therapy Beyond T Cell Targeting: Monocytes, B Cells, and Innate Lymphocytes

F. Susan Wong ,Li Wen

Read More

Targeted Antigen Delivery to DEC-205+ Dendritic Cells for Tolerogenic Vaccination

Cathleen Petzold, Sonja Schallenberg ,Joel N.H. Stern ,Karsten Kretschmer

Read More

Tolerance Strategies Employing Antigen-Coupled Apoptotic Cells and Carboxylated PLG Nanoparticles for the Treatment of Type 1 Diabetes

Suchitra Prasad, Dan Xu, Stephen D. Miller

Read More

Clinical Potential of Antigen-Specific Therapies in Type 1 Diabetes

Ken T. Coppieters ,Birgit Sehested Hansen ,Matthias G. von Herrath

Read More

Interleukin-1 Antagonists and Other Cytokine Blockade Strategies for Type 1 Diabetes

Thomas Mandrup-Poulsen

Read More

In Vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes

Valentina Di Caro, Nick Giannoukakis, Massimo Trucco

Read More

Immune-Directed Therapy for Type 1 Diabetes at the Clinical Level: The Immune Tolerance Network (ITN) Experience

Mario R. Ehlers ,Gerald T. Nepom

Read More

CD3 Monoclonal Antibodies: A First Step Towards Operational Immune Tolerance in the Clinic

Lucienne Chatenoud ,Herman Waldmann

Read More

Islet Transplantation in Type 1 Diabetes: Ongoing Challenges, Refined Procedures, and Long-Term Outcome

A.M. James Shapiro

Read More

Islet Neogenesis: A Possible Pathway for Beta-Cell Replenishment

Susan Bonner-Weir, Lili Guo, Wan-Chun Li, Limor Ouziel-Yahalom, Philippe A. Lysy, Gordon C. Weir, Arun Sharma

Read More